Hans‐Gregor Gattner

551 total citations
34 papers, 420 citations indexed

About

Hans‐Gregor Gattner is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Hans‐Gregor Gattner has authored 34 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Organic Chemistry. Recurrent topics in Hans‐Gregor Gattner's work include Chemical Synthesis and Analysis (7 papers), Peptidase Inhibition and Analysis (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Hans‐Gregor Gattner is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Peptidase Inhibition and Analysis (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Hans‐Gregor Gattner collaborates with scholars based in Germany, United States and Russia. Hans‐Gregor Gattner's co-authors include Dietrich Brandenburg, Axel Wollmer, Helmut Zahn, Alfred Jonczyk, Urs T. Rüegg, Waleed Danho, Vinod Κ. Naithani, Erika E. Büllesbach, Derek Saunders and Pierre De Meyts and has published in prestigious journals such as Biochemistry, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Hans‐Gregor Gattner

34 papers receiving 353 citations

Peers

Hans‐Gregor Gattner
G Krail Germany
James E. Shields United States
K. Eisler Switzerland
Agata A. Bielska United States
Mark J. Hunter Australia
Kenneth R. Isham United States
Marilynn S. Doscher United States
K. Anne Kronis United States
G Krail Germany
Hans‐Gregor Gattner
Citations per year, relative to Hans‐Gregor Gattner Hans‐Gregor Gattner (= 1×) peers G Krail

Countries citing papers authored by Hans‐Gregor Gattner

Since Specialization
Citations

This map shows the geographic impact of Hans‐Gregor Gattner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Gregor Gattner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Gregor Gattner more than expected).

Fields of papers citing papers by Hans‐Gregor Gattner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Gregor Gattner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Gregor Gattner. The network helps show where Hans‐Gregor Gattner may publish in the future.

Co-authorship network of co-authors of Hans‐Gregor Gattner

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Gregor Gattner. A scholar is included among the top collaborators of Hans‐Gregor Gattner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Gregor Gattner. Hans‐Gregor Gattner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lahann, Jörg, et al.. (2002). Universal Approach Towards r-Hirudin Derivatives with High Anti-Thrombin Activity Based on Chemical Differentiation of Primary Amino Groups. Macromolecular Bioscience. 2(2). 82–87. 7 indexed citations
2.
Klee, Doris, et al.. (2001). Immobilization of the thrombin inhibitor r-hirudin conserving its biological activity. Journal of Materials Science Materials in Medicine. 12(9). 807–810. 13 indexed citations
3.
Kurapkat, Günther, et al.. (1999). The solution structure of a superpotent b‐chain‐shortened single‐replacement insulin analogue. Protein Science. 8(3). 499–508. 13 indexed citations
4.
Hassiepen, Ulrich, et al.. (1998). Analysis of protein self‐association at constant concentration by fluorescence‐energy transfer. European Journal of Biochemistry. 255(3). 580–587. 9 indexed citations
5.
Gattner, Hans‐Gregor, et al.. (1995). The role of the C‐terminus of the insulin B‐chain in modulating structural and functional properties of the hormone. International journal of peptide & protein research. 46(5). 397–407. 8 indexed citations
6.
Gattner, Hans‐Gregor, et al.. (1995). Structure‐function relationships of des‐(B26‐B30)‐insulin. International journal of peptide & protein research. 46(3-4). 221–227. 4 indexed citations
7.
Federwisch, Matthias, Hans‐Gregor Gattner, Dietrich Brandenburg, et al.. (1995). Structure and Rotational Dynamics of Fluorescently Labeled Insulin in Aqueous Solution and at the Amphiphile-Water Interface of Reversed Micelles. Biochemistry. 34(18). 6130–6141. 15 indexed citations
8.
Hampl, Johannes, Dimitrij Plachov, Hans‐Gregor Gattner, et al.. (1991). Presentation of insulin and insulin a chain peptides to mouse T cells: Involvement of cysteine residues. Molecular Immunology. 28(4-5). 479–487. 10 indexed citations
9.
Naithani, Vinod Κ. & Hans‐Gregor Gattner. (1982). Preparation and Properties of Citraconylinsulins. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 363(2). 1443–1448. 4 indexed citations
10.
Saunders, Derek, et al.. (1982). [LeuB24]- and [LeuB25]Insulins are not Antagonists of Lipogenesis in Adipocytes. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 363(1). 187–192. 2 indexed citations
11.
Meyts, Pierre De, et al.. (1981). Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins. Biochemical and Biophysical Research Communications. 100(3). 1229–1236. 32 indexed citations
12.
Jonczyk, Alfred & Hans‐Gregor Gattner. (1981). Einde neue Semisynthese des Humanindulins. Tryptisch-katalysierte Transpeptidierung von Schweineinsulin mit L-Threonin-tert-butylester.. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 362(2). 1591–1598. 23 indexed citations
13.
Wollmer, Axel, W. Straßburger, Guy Dodson, et al.. (1981). Two Mutant Forms of Human Insulin. Structural Consequences of the Substitution of Invariant B24- or B25-Phenylalanine by Leucine. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 362(1). 581–592. 25 indexed citations
14.
Danho, Waleed, et al.. (1980). [A14-Phenylalanine]Insulin: A New Synthetic Analogue. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 361(1). 747–754. 8 indexed citations
15.
Gattner, Hans‐Gregor, et al.. (1978). Verbesserte Darstellung von Des-alanylB30-insulin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 359(2). 799–802. 16 indexed citations
16.
Brandenburg, Dietrich, et al.. (1977). Crosslinked Insulins: Preparation, Properties, and Applications. Advances in experimental medicine and biology. 86A. 261–282. 11 indexed citations
17.
Gattner, Hans‐Gregor, et al.. (1977). [A21-Asparaginimide] Insulin. Saponification of Insulin Hexamethyl Ester, I. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 358(1). 105–114. 12 indexed citations
18.
Gattner, Hans‐Gregor. (1975). B-Kettenverkürzung von polymergebundenem Insulin mit Pepsin, I. Darstellung und Eigenschaften von Des-Pentapeptid (B26-30)-Rinderinsulin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 356(2). 1397–1404. 42 indexed citations
19.
Danho, Waleed, et al.. (1975). B-Chain Shortening of Matrix-Bound Insulin with Pepsin, II. Preparation and Properties of Camel Des-Pentapeptide(B26-30)- and Des-PheB1-des-Pentapeptide(B26-30)-Insulin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 356(2). 1405–1412. 1 indexed citations
20.
Zahn, Helmut & Hans‐Gregor Gattner. (1968). Über die partielle Reduktion von Insulin. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 349(1). 373–384. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026